MetLife Price Target Lowered to $98 by Morgan Stanley
ByAinvest
Tuesday, Jul 15, 2025 7:36 pm ET1min read
JPM--
Despite the reduction in the price target, Morgan Stanley's overall outlook on MetLife remains positive, as evidenced by the continued "Overweight" rating. This rating suggests that the analysts expect MetLife's stock to perform better than the market average over the next 12 months.
The latest adjustment follows a series of updates from various analysts. Keefe, Bruyette & Woods, for instance, cut their price target for MetLife from $95.00 to $94.00, also maintaining an "outperform" rating [2]. Wells Fargo & Company raised their target price from $91.00 to $94.00, while Morgan Stanley initially boosted their target from $94.00 to $99.00. JPMorgan Chase & Co. also increased their target from $86.00 to $95.00, and Piper Sandler raised their target from $92.00 to $94.00 [2].
The consensus among analysts is that MetLife's stock is currently undervalued, with the average target price standing at $95.25, implying an upside of 22.37% from the current price of $77.84 [1]. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1 [1].
MetLife's recent earnings report showed strong performance, with earnings per share (EPS) of $1.96 for the quarter, up 15.6% from the same period last year. The company also authorized a share buyback plan, indicating confidence in its stock's valuation [2]. Institutional investors have been increasing their stakes in MetLife, with several major investors boosting their positions in the second quarter [2].
References:
[1] https://www.gurufocus.com/news/2975406/met-morgan-stanley-adjusts-price-target-for-metlife-met-stock-news
[2] https://www.marketbeat.com/instant-alerts/metlife-nysemet-price-target-cut-to-9400-by-analysts-at-keefe-bruyette-woods-2025-07-09/
MET--
MS--
PIPR--
WFC--
Morgan Stanley analyst Bob Huang has lowered MetLife's (MET) price target to $98 from $99 while maintaining an Overweight rating on the shares.
Morgan Stanley analyst Bob Huang has adjusted the price target for MetLife (MET) from $99.00 to $98.00 USD, while maintaining an "Overweight" rating on the shares [1]. This adjustment reflects a slight downward revision in the projected value of MetLife's stock, indicating a 1.01% decrease in the price target.Despite the reduction in the price target, Morgan Stanley's overall outlook on MetLife remains positive, as evidenced by the continued "Overweight" rating. This rating suggests that the analysts expect MetLife's stock to perform better than the market average over the next 12 months.
The latest adjustment follows a series of updates from various analysts. Keefe, Bruyette & Woods, for instance, cut their price target for MetLife from $95.00 to $94.00, also maintaining an "outperform" rating [2]. Wells Fargo & Company raised their target price from $91.00 to $94.00, while Morgan Stanley initially boosted their target from $94.00 to $99.00. JPMorgan Chase & Co. also increased their target from $86.00 to $95.00, and Piper Sandler raised their target from $92.00 to $94.00 [2].
The consensus among analysts is that MetLife's stock is currently undervalued, with the average target price standing at $95.25, implying an upside of 22.37% from the current price of $77.84 [1]. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1 [1].
MetLife's recent earnings report showed strong performance, with earnings per share (EPS) of $1.96 for the quarter, up 15.6% from the same period last year. The company also authorized a share buyback plan, indicating confidence in its stock's valuation [2]. Institutional investors have been increasing their stakes in MetLife, with several major investors boosting their positions in the second quarter [2].
References:
[1] https://www.gurufocus.com/news/2975406/met-morgan-stanley-adjusts-price-target-for-metlife-met-stock-news
[2] https://www.marketbeat.com/instant-alerts/metlife-nysemet-price-target-cut-to-9400-by-analysts-at-keefe-bruyette-woods-2025-07-09/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet